Apalutamide Recruiting Phase 2 Trials for Stage III Prostate Adenocarcinoma / PSA Progression / Stage IV Prostate Adenocarcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03371719Radiation Therapy With or Without Apalutamide in Treating Patients With Stage III-IV Prostate Cancer